Reactivated varicella zoster virus may cause peripheral arterial thrombosis.
Tezcan
Mehmet Engin
ME
Teksut
Tuba Kuz
TK
Onal
Ahmet Baran
AB
Oztürk
Mehmet Akif
MA
D000212:Acyclovir / Q000627:therapeutic use; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D019433:Chickenpox Vaccine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006562:Herpes Zoster / Q000473:pathology / Q000821:virology*; D014645:Herpesvirus 3, Human; D006801:Humans; D008297:Male; D016491:Peripheral Vascular Diseases / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D013927:Thrombosis / Q000473:pathology / Q000821:virology*; D016896:Treatment Outcome; D014613:Vaccines, Attenuated / Q000009:adverse effects*
D000925:Anticoagulants; D000998:Antiviral Agents; D019433:Chickenpox Vaccine; D014613:Vaccines, Attenuated; D006493:Heparin; D000212:Acyclovir